Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stimuli-responsive gene delivery vectors.

David Oupický1, Veena Diwadkar

  • 1Department of Pharmaceutical Sciences, Wayne State University, Detroit, MI 48202, USA. oupicky@wayne.edu

Current Opinion in Molecular Therapeutics
|September 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor Lipidomic Changes after Treatment with Polymeric Hydroxychloroquine in a Syngeneic Murine Model of Pancreatic Cancer.

ACS omega·2026
Same author

Structure-Activity Mapping of Intraperitoneal mRNA-LNPs: Decoupling Tumor and Liver Biodistribution in Pancreatic Cancer.

bioRxiv : the preprint server for biology·2026
Same author

PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4.

Molecular cancer therapeutics·2026
Same author

Inhalable perfluorocarbon RNA nanocapsules overcome biological barriers to treat lung metastases.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Reactive Oxygen Species-Responsive Polymeric Chloroquine Nanogel for Targeted Oral Therapy of Ulcerative Colitis.

ACS applied materials & interfaces·2025
Same author

PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4.

bioRxiv : the preprint server for biology·2025
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Responsive non-viral vectors overcome gene delivery barriers by adapting their properties. These smart delivery systems are crucial for efficient gene therapy, addressing challenges in cellular targeting and nuclear entry.

Area of Science:

  • Biotechnology and Biomedical Engineering
  • Molecular Biology and Genetics

Background:

  • Non-viral vectors face significant biological barriers for efficient gene delivery, from administration site to the cell nucleus.
  • These barriers necessitate vectors with diverse and often contradictory properties, posing a major challenge for synthetic vector design.

Purpose of the Study:

  • To review recent advancements in stimuli-responsive gene delivery vectors.
  • To highlight vectors that dynamically alter properties in response to environmental cues for improved gene delivery.

Main Methods:

  • Literature review of recent research on stimuli-responsive gene delivery systems.
  • Analysis of vector designs that respond to endogenous and exogenous stimuli.

Main Results:

Related Experiment Videos

  • Development of vectors that change properties (e.g., charge, size, conformation) in response to stimuli like pH, temperature, or specific molecules.
  • Demonstration of improved cellular uptake, endosomal escape, and nuclear translocation by responsive vectors.

Conclusions:

  • Stimuli-responsive vectors represent a promising strategy to overcome gene delivery barriers.
  • Dynamic adaptation of vector properties is key to enhancing the efficiency and safety of non-viral gene delivery systems.